Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 EUR | +8.00% | +8.00% | +12.03% |
Apr. 22 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
Apr. 11 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |
- Stock Market
- Equities
- ADMIN Stock
- News Administer Oyj
- Trading Ideas